CLINICAL TRIALS

Open Access
Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study
Christopher J. Edwards, Gerhard Krönke, Jérôme Avouac, Zhanguo Li, Fabrizio Conti, Alejandro Balsa, Daojun Mo, Ewa Haladyj, Peter Fischer, Masaru Tanaka, Yasushi Takita, Kohei Hagimori and Tsutomu Takeuchi

The Journal of Rheumatology April 1 2025, 52 (4) 316-322; DOI: https://doi.org/10.3899/jrheum.2024-0906
Open Access
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies
Victoria Navarro-Compán, Martin Rudwaleit, Maureen Dubreuil, Marina Magrey, Helena Marzo-Ortega, Philip J. Mease, Jessica A. Walsh, Maxime Dougados, Christine de la Loge, Carmen Fleurinck, Ute Massow, Thomas Vaux, Vanessa Taieb and Atul Deodhar

The Journal of Rheumatology January 1 2025, 52 (1) 23-32; DOI: https://doi.org/10.3899/jrheum.2024-0223
Open Access
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)
Gerd R. Burmester, Filip Van den Bosch, John Tesser, Anna Shmagel, Yanxi Liu, Nasser Khan, Heidi S. Camp and Alan Kivitz

The Journal of Rheumatology July 1 2024, 51 (7) 663-672; DOI: https://doi.org/10.3899/jrheum.2023-1062
Open Access
Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program
Atul Deodhar, Denis Poddubnyy, Proton Rahman, Jeorg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araújo, Ann Leung and Désirée van der Heijde

The Journal of Rheumatology August 1 2023, 50 (8) 1020-1028; DOI: https://doi.org/10.3899/jrheum.221022
Open Access
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial
Emilce E. Schneeberger, Gustavo Citera, Dario Ponce de Leon, Annette E. Szumski, Kenneth Kwok, Mariel Cutri and Maxime Dougados

The Journal of Rheumatology October 1 2022, 49 (10) 1100-1108; DOI: https://doi.org/10.3899/jrheum.211075
Open Access
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials
Louis Bessette, Eduardo Mysler, Cassandra D. Kinch, Kenneth Kwok, Tatjana Lukic, Phu Vinh On and Ronald F. van Vollenhoven

The Journal of Rheumatology June 1 2022, 49 (6) 566-576; DOI: https://doi.org/10.3899/jrheum.210707
Open Access
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee
Philip G. Conaghan, Robert H. Dworkin, Thomas J. Schnitzer, Francis Berenbaum, Andrew G. Bushmakin, Joseph C. Cappelleri, Lars Viktrup and Lucy Abraham

The Journal of Rheumatology June 1 2022, 49 (6) 615-621; DOI: https://doi.org/10.3899/jrheum.210543
You have access
Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study
Charlotte L. Bekker, Sacha Bossina, Mary A. de Vera, Susan J. Bartlett, Maarten de Wit, Lyn March, Beverley Shea, Vicki Evans, Dawn Richards, Allison Tong, Peter Tugwell, Kathleen Tymms, Marieke Scholte-Voshaar, Ayano Kelly and Bart J.F. van den Bemt

The Journal of Rheumatology September 1 2021, 48 (9) 1480-1487; DOI: https://doi.org/10.3899/jrheum.201568
You have access
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis
Peter C. Taylor, Désirée van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng and Annelies Boonen

The Journal of Rheumatology August 1 2021, 48 (8) 1259-1267; DOI: https://doi.org/10.3899/jrheum.201088
You have access
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review
Ayano Kelly, Luke Crimston-Smith, Allison Tong, Susan J. Bartlett, Charlotte L. Bekker, Robin Christensen, Mary A. De Vera, Maarten de Wit, Vicki Evans, Michael Gill, Lyn March, Karine Manera, Robby Nieuwlaat, Shahrzad Salmasi, Marieke Scholte-Voshaar, Jasvinder A. Singh, Daniel Sumpton, Karine Toupin-April, Peter Tugwell, Bart van den Bemt, Suzanne Verstappen and Kathleen Tymms

The Journal of Rheumatology October 1 2020, 47 (10) 1565-1574; DOI: https://doi.org/10.3899/jrheum.190726

Main menu

User menu

Search

CLINICAL TRIALS

Pages

Content

Resources

Subscribers

More